The global burden of typhoid fever

Bulletin of the World Health Organization

Volumn 82, Issue 5, 2004, Pages 346-353

  Crump, John A ^a,b   Luby, Stephen P ^b   Mintz, Eric D ^b  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Cohort studies; Cost of illness; Paratyphoid fever epidemiology; Population surveillance; Salmonella enterica isolation and purification; Sensitivity and specificity; Typhoid fever epidemiology blood

Indexed keywords

COHORT ANALYSIS; COST; DISEASE PREVALENCE; GLOBAL PERSPECTIVE; MEDICAL GEOGRAPHY; TYPHOID;

AGE DISTRIBUTION; ARTICLE; ASIA; BLOOD CULTURE; CARIBBEAN ISLANDS; COMPUTER SYSTEM; DATA ANALYSIS; DECISION MAKING; DIAGNOSTIC ACCURACY; DISEASE CONTROL; EUROPE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; NORTH AMERICA; POPULATION RESEARCH; PUBLIC HEALTH; SALMONELLOSIS; SENSITIVITY ANALYSIS; TYPHOID FEVER;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MIDDLE AGED; POPULATION SURVEILLANCE; SENSITIVITY AND SPECIFICITY; TYPHOID FEVER; WORLD HEALTH;

EID: 2642571836     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. The world health report 1995: Fighting disease, fostering development. Geneva: World Health Organization; 1996.
2. Edelman R, Levine MM. Summary of an international workshop on typhoid fever. Reviews of Infectious Diseases 1986;8:329-49.
3. Institute of Medicine. New vaccine development: establishing priorities, Vol. 2. Diseases of importance in developing countries. Comparisons of disease burdens. Washington (DC): National Academy Press; 1986.
4. The sex and age distribution of the world populations. The 1996 revision. New York: United Nations; 1997.
5. WHO/UNICEF Joint Monitoring Programme for Water Supply and Sanitation. Global water supply and sanitation assessment 2000 report. Geneva: WHO/UNICEF; 2000.
6. Martinez L. Global infectious disease surveillance. International Journal of Infectious Diseases 2000;4:222-8.
7. Lin F-YC, Ho VA, Bay PV, Thuy NTT, Bryla D, Thanh TC, et al. The epidemiology of typhoid fever in the Dong Thap Province, Mekong Delta region of Vietnam. The American Journal of Tropical Medicine and Hygiene 2000;62:644-8.
8. Sinha A, Sazawal S, Kumar R, Sood S, Reddaiah VP, Singh B, et al. Typhoid fever in children aged less than 5 years. Lancet 1999;354:734-7.
9. Yang HH, Wu CG, Xie GZ, Gu QW, Wang BR, Wang LY, et al. Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south-western China. Bulletin of the World Health Organization 2001;79:625-31.
10. Murray CJL, Lopez AD. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1991 and projected to 2020. In: Murray CJL, Lopez AD, editors. Global burden of disease and injury series, 1st ed. Vol. 1. Boston (MA): Harvard University Press; 1996.
11. United Nations Children's Fund. The state of the world's children 1996. New York: Oxford University Press; 1996.
12. Hoffman SL, Edman DC, Punjabi NH, Lesmana M, Cholid A, Sundah S, et al. Bone marrow aspirate culture superior to streptokinase clot culture and 8 mL 1:10 blood-to-broth ratio blood culture for diagnosis of typhoid fever. The American Journal of Tropical Medicine and Hygiene 1986;35:836-9.
13. Gilman RH, Terminel M, Levine MM, Hernandez-Mendoza P, Hornick RB. Relative efficacy of blood, urine, rectal swab, bone-marrow, and rose-spot cultures for recovery of Salmonella Typhi in typhoid fever. Lancet 1975;1:1211-3.
14. Wain J, Bay PVB, Vinh H, Duong NM, Diep TS, Walsh AL, et al. Quantitation of bacteria in bone marrow from patients with typhoid fever: relationship between counts and clinical features. Journal of Clinical Microbiology 2001;39:1571-6.
15. Herikstad H, Motarjemi Y, Tauxe RV. Salmonella surveillance: a global survey of public health serotyping. Epidemiology and Infection 2002;129:1-8.
16. Butler T, Knight J, Nath SK, Speelman P, Roy SK, Azad MAK. Typhoid fever complicated by intestinal perforation: a persisting fatal disease requiring surgical management. Reviews of Infectious Diseases 1985;7:244-56.
17. Helfrick DL, Olsen SJ, Bishop RD, Tauxe RV, Hoekstra RM, Slutsker L, et al. An atlas of Salmonella in the United States: serotype-specific surveillance, 1968-1998. Atlanta (GA): United States Department of Health and Human Services; 2000.
18. Black RE, Levine MM, Ferreccio C, Clements ML, Lanata C, Rooney J, et al. Efficacy of one or two doses of Ty21a Salmonella Typhi vaccine in enteric-coated capsules in a controlled field trial. Vaccine 1990;8:81-4.
19. Simanjuntak CH, Paleologo FP, Punjabi NH, Darmowigoto R, Soeprawoto, Totosudirjo H, et al. Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine. Lancet 1991;338:1055-9.
20. Hejfec LB. Results of the study of typhoid vaccines in four controlled field trials in the USSR. Bulletin of the World Health Organization 1965;32:1-14.
21. Hejfec LB, Salmin LV, Lejtman MZ, Kuz'minova ML, Vasil'eva AV, Levina LA, et al. A controlled field trial and laboratory study of five typhoid vaccines in the USSR. Bulletin of the World Health Organization 1966;34:321-39.
22. Hejfec LB, Levina LA, Kuz'minova ML, Salmin LV, Slavina AM, Vasil'eva AV. Controlled field trials of paratyphoid B vaccine and evaluation of the effectiveness of a single administration of typhoid vaccine. Bulletin of the World Health Organization 1968;38:907-15.
23. Yugoslav Typhoid Commission. A controlled field trial of the effectiveness of phenol and alcohol typhoid vaccines. Bulletin of the World Health Organization 1962;26:357-69.
24. Yugoslav Typhoid Commission. A controlled field trial of the effectiveness of acetone-dried and inactivated and heat-phenol-inactivated typhoid vaccines in Yugoslavia. Bulletin of the World Health Organization 1964;30:623-30.
25. Levine MM, Ferreccio C, Black RE, Germanier R. Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation. Lancet 1987;1:1049-52.
26. Levine MM, Ferreccio C, Cryz S, Ortiz E. Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial. Lancet 1990;336:891-4.
27. Wahdan MH, Sippel JE, Mikhail JA, Rahka AE, Anderson ES, Sparks HA, et al. Controlled field trial of a typhoid vaccine prepared with a nonmotile mutant of Salmonella Typhi Ty2. Bulletin of the World Health Organization 1975;52:69-73.
28. Wahdan MH, Serie C, Cerisier Y, Sallam S, Germanier R. A controlled field trial of live Salmonella Typhi strain Ty21a oral vaccine against typhoid: three-year results. The Journal of Infectious Diseases 1982;145:292-5.
29. Ashcroft MT, Singh B, Nicholson CC, Ritchie JM, Sobryan E, Williams F. A seven-year field trial of two typhoid vaccines in Guyana. Lancet 1967;2:1056-9.
30. Chuttani CS, Prakash K, Gupta P, Grover V, Kumar A. Controlled field trial of high-dose oral killed typhoid vaccine in India. Bulletin of the World Health Organization 1977;55:643-4.
31. Hejfec LB, Levina LA, Kuz'minova ML, Slavina AM, Drozd AK, Tonojan IA, et al. A controlled field trial to evaluate the protective capacity of a single dose of acetone-killed agar-grown and heat-killed broth-grown typhoid vaccines. Bulletin of the World Health Organization 1969;40:903-7.
32. Ying FY, Ho VA, Kheim HB, Trach DD, Bay PV, Thanh TC, et al. The efficacy of a Salmonella Typhi Vi conjugate vaccine in two-to-five-year-old children. The New England Journal of Medicine 2001;344:1263-9.
33. El-Rafie M, Hassouna WA, Hirschhorn N, Loza S, Miller P, Nagaty A, et al. Effect of diarrhoeal disease control on infant and childhood mortality in Egypt. Report from the National Control of Diarrhoeal Diseases Project. Lancet 1990;335:334-8.
34. Woods CW, Murdoch DR, Zimmerman MD, Belbase RH, Basnyat B, Archibald LK, et al. Etiology of febrile illness in urban Nepal. The American Journal of Tropical Medicine and Hygiene 2001;65:149.
35. Archibald LK, den Dulk MO, Pallangyo KJ, Reller LB. Fatal Mycobacterium tuberculosis bloodstream infections in febrile hospitalized adults in Dar es Salaam, Tanzania. Clinical Infectious Diseases 1998;26:290-6.
36. Archibald LK, McDonald LC, Nwanyanwu O, Kazembe P, Dobbie H, Tokars J, et al. A hospital-based prevalence survey of bloodstream infections in febrile patients in Malawi: implications for diagnosis and therapy. The Journal of Infectious Diseases 2000;181:1414-20.
37. Vugia DJ, Kiehlbauch JA, Yeboue K, N'Gichi JM, Lacina D, Maran M, et al. Pathogens and predictors of fatal septicemia associated with human immunodeficiency virus infection in Ivory Coast, West Africa. The Journal of Infectious Diseases 1993;168:564-70.
38. Polish Typhoid Committee. Evaluation of typhoid vaccines in the laboratory and in a controlled field trial in Poland. Bulletin of the World Health Organization 1965;32:15-27.
39. Tapa S, Cvjetanovic B. Controlled field trial on the effectiveness of one and two doses of acetone-inactivated and dried typhoid vaccine. Bulletin of the World Health Organization 1975;52:75-80.
40. Okeke IN, Lamikanra A, Edelman R. Socioeconomic and behavioral factors leading to acquired bacterial resistance in developing countries. Emerging Infectious Diseases 1999;5:18-27.
41. Crump JA, Youssef FG, Luby SP, Wasfy MO, Rangel JM, Talaat M, et al. Estimating the incidence of typhoid fever and other febrile illnesses in developing countries. Emerging Infectious Diseases 2003;9:539-44.
42. Klugman KP, Gilbertson IT, Koornhof HJ, Robbins JB, Schneerson R, Schulz D, et al. Protective activity of Vi capsular polysaccharide vaccine against typhoid fever. Lancet 1987;2:1165-9.
43. Klugman KP, Koornhof HJ, Robbins JB, Le Cam NN. Immunogenicity, efficacy, and serological correlate of protection of Salmonella Typhi Vi capsular polysaccharide vaccine three years after immunization. Vaccine 1996;14:435-8.
44. Acharya IL, Lowe CU, Thapa R, Gurubacharya VL, Shrestha MB, Cadoz M, et al. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella Typhi. The New England Journal of Medicine 1987;317:1101-4.